“The ball is now in the organization’s court to perform postmarket reports and surveillance on buyer influence, also to submit this info to FDA annually,” said Dr. King. “If scientific proof indicates which the net gains of such items no longer outweigh the risks with the population stage—or if the organization fails to perform the needed… Read More